Journal of the Formosan Medical Association
Volume 105, Issue 5 , Pages 377-383 , 2006

Pericardial Fluid and Serum Levels of Vascular Endothelial Growth Factor and Endostatin in Patients With or Without Coronary Artery Disease

  • Jer-Young Liou
    • ,
  • Pei-Liang Kuan

      Affiliations

    • Corresponding Author InformationCorrespondence to: Dr. Pei-Liang Kuan, Division of Cardiology, Shin Kong Wu Ho-Su Memorial Hospital, 95 Wen-Chang Road, Taipei 111, Taiwan
  • Kou-Gi Shyu

      Affiliations

    • Department of Education and Research, Taipei, Taiwan
    • Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan
    • ,
  • Ming-Jen Lu

      Affiliations

    • Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
    • ,
  • Hung-Hsin Chao

      Affiliations

    • Department of Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan
    • ,
  • Bao-Wei Wang

      Affiliations

    • Department of Education and Research, Taipei, Taiwan

Received 7 July 2005 ,Revised 18 August 2005 ,Accepted 4 October 2005.

References 

  1. Coats AJS . Pericardial fluid-dispensable or indispensable fluid and an example of patentable biodiversity . Int J Cardiol . 2001;77:109–111
  2. Fujita M , Komeda M , Hasegawa K , et al.   Pericardial fluid as a new material for clinical heart research . Int J Cardiol . 2001;77:113–118
  3. O'Reilly MS , Boehm T , Shing Y , et al.   Endostatin: an endogenous inhibitor of angiogenesis and tumor growth . Cell . 1997;88:277–285
  4. Yoon SS , Eto H , Lin CM , et al.   Mouse endostatin inhibits the formation of lung and liver metastasis . Cancer Res . 1999;59:6251–6256
  5. Perletti G , Concari P , Giardini RJ , et al.   Anti-tumor activity of endostatin against carcinogen-induced rat primary mammary tumors . Cancer Res . 2000;60:1793–1796
  6. Yokoyama Y , Green JE , Sukhatme VP , et al.   Effect of endostatin on spontaneous tumorigenesis of mammary adenocarcinomas in a transgenic mouse model . Cancer Res . 2000;60:4362–4365
  7. Ding I , Sun JZ , Fenton B , et al.   Intramural administration of endostatin plasmid inhibits vascular growth and perfusion in Mca-4 murine mammary carcinomas . Cancer Res . 2001;61:526–531
  8. Dixelius J , Larrson H , Sasaki T , et al.   Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis . Blood . 2000;95:3403–3411
  9. Dhar DK , Ono T , Yamanoi A , et al.   Serum endostatin predicts tumor vascularity in hepatocellular carcinoma . Cancer . 2002;95:2188–2195
  10. Bono P , Teeerenhovi L , Joensuu H . Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma . Cancer . 2003;97:2767–2775
  11. Zhao J , Yan F , Ju H , et al.   Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer . Cancer Lett . 2004;204:87–95
  12. Shweiki D , Itin A , Soffer D , et al.   Vascular endothelial growth factor induced by hypoxia may mediate hypoxiainitiated angiogenesis . Science . 1992;359:843–845
  13. Plate KH , Breier G , Weich HA , et al.   Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo . Nature . 1992;359:845–848
  14. Lee SH , Wolf PL , Escudero R , et al.   Early expression of angiogenesis factors in acute myocardial ischemia and infarction . N Engl J Med . 2000;342:626–633
  15. Kranz-Rau C , Kochs M , Waltenberger J . Elevation of vascular endothelial growth factor-A serum levels following acute myocardial infarction. Evidence for its origin and functional significance . J Mol Cell Cardiol . 2000;32:65–72
  16. Panchal VR , Rehman J , Nguyen AT , et al.   Reduced pericardial levels of endostatin correlate with collateral development in patients with ischemic heart disease . J Am Coll Cardiol . 2004;43:1383–1387
  17. Rentrop KP , Cohen M , Blanke H , et al.   Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects . J Am Coll Cardiol . 1985;5:587–592
  18. Blann AD , Belgore FM , McCollum CN , et al.   Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or type II diabetes . Clin Sci . 2002;102:187–194
  19. Gerrah R , Tshori S , Gilon D . Pericardial fluid and serum VEGF in response to different types of heparin treatment . Int J Cardiol . 2004;94:193–196
  20. Losordo DW , Vale PR , Symes JF , et al.   Therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia . Circulation . 1998;98:2800–2804
  21. Hojo Y , Ikeda U , Zhu Y , et al.   Expression of vascular endothelial growth factor in patients with acute myocardial infarction . J Am Coll Cardiol . 2000;35:968–973
  22. Chilian WM , Mass HJ , Williams SE , et al.   Microvascular occlusions promote collateral growth . Am J Physiol . 1990;258:H1103–H1111
  23. Weihrauch D , Tessmer J , Wartier  , et al.   Repetitive coronary artery occlusion induce release of growth factors into the myocardial interstitium . Am J Physiol . 1998;275:H969–H976
  24. Alber HF , Frick M , Dulak J , et al.   Vascular endothelial growth factor (VEGF) plasma concentrations in coronary artery disease . Heart . 2005;91:365–366
  25. Zachary I , Mathur A , Yla-Herttuala S , et al.   Vascular protection: a novel nonangiogenic cardiovascular role for vascular endothelial growth factor . Arterioscler Thromb Vasc Biol . 2000;20:1512–1520
  26. Fujita M , Ikemoto M , Kishishita M , et al.   Elevated basic fibroblast growth factor in pericardial fluid of patients with unstable angina . Circulation . 1996;94:610–613
  27. Ikonomidis I , Andreotti F , Economou E , et al.   Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin . Circulation . 1997;96:3542–3548
  28. Schaper W , Ito W . Molecular mechanisms of coronary collateral vessel growth . Circ Res . 1996;79:911–919

PII: S0929-6646(09)60133-9

doi: 10.1016/S0929-6646(09)60133-9

Journal of the Formosan Medical Association
Volume 105, Issue 5 , Pages 377-383 , 2006

Article Tools